Drug Discovery

In addition to Nyrada’s lead Cardiovascular and Neuroprotection drug development programs, the Company is investigating drugs to treat pain associated with peripheral nerve damage (Inflammation/Pain) and autoimmune diseases such as psoriasis (Autoimmune).

The Inflammation/Pain and Autoimmune programs are part of a larger pipeline of potential drug candidates that Nyrada continues to evaluate and develop, while focusing on the progression of its two lead drug development programs.

Further information in relation to the Company’s drug discovery program is available below: